SI-BONE stock gets a higher Jefferies target as Onyx expands reach
Published on 10/05/2026 at 20:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
SI-BONE stock (ISIN US8257041090) was trading at USD 19.52 on Nasdaq on October 5, 2026 at 2:48 p.m. ET, up 7.96 percent from the prior close. The immediate market story is a Jefferies target increase from USD 23 to USD 25, while the company advances its first product for compromised bone outside the pelvis.
Jefferies lifts the target
Futu reported on October 5, 2026 that Jefferies raised its SI-BONE target to USD 25 from USD 23. The new target lies 28.1 percent above the October 5 trading price, giving the analyst action a concrete valuation reference.
The broader analyst picture is also constructive. ToAlpha listed a consensus rating based on 9 analysts, with a USD 25.00 average target, a USD 20.00 low and a USD 32.00 high as of September 28, 2026.
Onyx expands the addressable market
SI-BONE received FDA 510(k) clearance for the iFuse Granite Onyx System on September 28, 2026. According to GlobeNewswire, the product is the companys first solution for compromised bone intended for use outside the pelvis.
Onyx addresses screw loosening in spinal fusion constructs, a problem occurring in up to 27 percent of constructs, and is designed for patients with low bone density. The clearance therefore gives SI-BONE a direct route into a larger spinal fusion market while extending its existing 3D-printed bone integration platform.
Revenue growth meets execution risk
SI-BONE reported USD 56.0 million of Q2 2026 revenue, up 15.2 percent year over year, while diluted EPS was negative USD 0.09. ToAlpha also lists a 79.5 percent gross margin for the quarter.
Managements growth strategy now depends on converting product expansion into procedures and recurring demand. A recent company filing also disclosed a voluntary recall of 98 iFuse TORQ implants and an expected charge of up to USD 150,000 across the third and fourth quarters, according to StockTitan on September 11, 2026.
Nasdaq price and valuation
SIBN was last at USD 19.52 on Nasdaq on October 5, 2026 at 2:48 p.m. ET, with a session range of USD 18.37 to USD 19.61. Its 52-week range was USD 11.48 to USD 21.89, and market capitalization stood at USD 865.7 million on the same date.
SI-BONE stock facts
- Company: SI-BONE, Inc.
- ISIN: US8257041090
- Ticker: SIBN
- Trading venue: Nasdaq
- Price (as of October 5, 2026, 2:48 p.m. ET): USD 19.52
- Market capitalization: USD 865.7 million (as of October 5, 2026)
- 52-week range: USD 11.48-USD 21.89 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical devices
